GSK (MEX:GSK N) Short-Term Debt : MXN0 Mil (As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is GSK Short-Term Debt?

GSK's Short-Term Debt for the quarter that ended in Mar. 2025 was MXN0 Mil.

GSK's quarterly Short-Term Debt increased from Sep. 2024 (MXN0 Mil) to Dec. 2024 (MXN57,505 Mil) but then declined from Dec. 2024 (MXN57,505 Mil) to Mar. 2025 (MXN0 Mil).

GSK's annual Short-Term Debt declined from Dec. 2022 (MXN89,881 Mil) to Dec. 2023 (MXN57,089 Mil) but then increased from Dec. 2023 (MXN57,089 Mil) to Dec. 2024 (MXN57,505 Mil).

GSK Short-Term Debt Historical Data

The historical data trend for GSK's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Short-Term Debt Chart

GSK Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

93,444.27

92,694.91

89,881.07

57,089.34

57,504.78

GSK Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	57,504.78	-

GSK Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

GSK Short-Term Debt Related Terms

Thank you for viewing the detailed overview of GSK's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK:USA GSK1:Mexico GSKl:UK GSK:UK GS70:Germany GS71:Germany GS71:Germany GS70:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

79 New Oxford Street, London, GBR, WC1A 1DG

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines